Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Carcinoma, Non-Small-Cell Lung 131Squamous Cell Carcinoma of Head and Neck 75Lung Neoplasms 47Head and Neck Neoplasms 45Urinary Bladder Neoplasms 43Parkinson Disease 4, Autosomal Dominant Lewy Body 33Oropharyngeal Neoplasms 32Nasopharyngeal Carcinoma 31Biliary Tract Neoplasms 31Uterine Cervical Neoplasms 29Cholangiocarcinoma 28Esophageal Squamous Cell Carcinoma 24Neoplasms 23Carcinoma 23Neoplasm Metastasis 22Small Cell Lung Carcinoma 21Ovarian Neoplasms 21Carcinoma, Squamous Cell 20Stomach Neoplasms 18Colorectal Neoplasms 18Carcinoma, Transitional Cell 17Pancreatic Neoplasms 16Esophageal Neoplasms 16Mesothelioma, Malignant 15Gallbladder Neoplasms 15Mouth Neoplasms 14Laryngeal Neoplasms 13Hypopharyngeal Neoplasms 12Endometrial Neoplasms 11Triple Negative Breast Neoplasms 10

Interventions

Magnetic Resonance Spectroscopy 3Cisplatin 3Carboplatin 3Platinum 2Methods 2Fluorodeoxyglucose F18 2FAPI-46 2Etoposide 2veliparib 1trastuzumab deruxtecan 1sodium thiosulfate 1brodalumab 1Taxes 1Surveys and Questionnaires 1Specimen Handling 1Psychology, Positive 1Psychiatric Nursing 1Physical Therapy Modalities 1Paclitaxel 1Neoadjuvant Therapy 1Mental Status and Dementia Tests 1Interviews as Topic 1Hearing 1Exercise 1Educational Status 1Costs and Cost Analysis 1Blood Specimen Collection 1Bleomycin 1Aspirin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Testicular Neoplasms × Cisplatin × 1 year × Clear all
NCT07218913 2026-04-17

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

City of Hope Medical Center

Phase 1 Recruiting
44 enrolled
Genitourinary

Testicular Neoplasms, Seminoma, Hearing Loss

NCT03937843 2026-01-20

Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma

Swiss Cancer Institute

Phase 2 Active not recruiting
135 enrolled
Genitourinary

Testicular Neoplasms, Seminoma

NCT02341989 2025-12-02

SWENOTECA-ABC

St. Olavs Hospital

Phase 3 Active not recruiting
348 enrolled
Genitourinary

Recurrence, Testicular Neoplasms, Seminoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡